产品详情 |
Edit |   |
Product Name | Trastuzumab (Herceptin) Immunogenicity ELISA |
Description | The Trastuzumab immunogenicity assay employs the bridging ELISA technique. A precoated 96 well capture antibody plate is provided. Quality control and test samples are pipetted into the appropriate wells. Anti-Trastuzumab present in biological matrices binds the immobilized capture antibody. After washing away any unbound substances, secondary antibody is added to the wells and after a final wash a detection reagent is added. The plate is washed to remove any unbound antibody-enzyme reagent and a substrate solution is added to the wells for color development. The color development is proportional to the amount of anti-Trastuzumab present in test samples. Four levels of QC samples give a qualitative reference signal which can be used to determine the level (High, Medium, Low, Negative) of anti-Trastuzumab antibody in the unknown samples. Range: 125ng/ml - 31.25ng/ml. Sample types: serum, plasma. Reactivity: human/mouse/rat. |
Size | 1X96 wells |
Concentration | n/a |
Applications | Quantification of antibodies to Trastuzumab |
Other Names | EIA, enzyme immunoassay, assay |
Gene, Accession, CAS # | Gene ID: 2064 |
Catalog # | EL-141-201 |
Price | |
Order / More Info | Trastuzumab (Herceptin) Immunogenicity ELISA from AFFINITY IMMUNO INC. |
Product Specific References | n/a |
产品资料 |
|
|